Please find enclosed Investor Presentation for Q4FY202526.
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GPT Healthcare reported FY26 revenue of ₹478.5 Cr (up 15.14% YoY) but PAT declined 15.43% to ₹42.2 Cr, driven primarily by losses at the newly commissioned Raipur hospital which posted EBITDA of -₹13.8 Cr and occupancy of only 12.35%. Mature hospitals delivered healthy EBITDA of ₹103.9 Cr with 23.06% margin. ARPOB improved to ₹39,243 from ₹37,180, reflecting stronger clinical mix. Overall EBITDA margin contracted to 18.84% from 22.10% in FY25. A turnaround is noted at ILS Dum Dum following restructuring and launch of cardiac surgery services. The company has a 150-bed Jamshedpur project underway with INR 75 Cr investment, targeting commissioning by end-FY27, and a stated goal to scale to 1,000+ beds. The balance sheet remains net-cash with over 90% revenue from cash and insured patients.
The Raipur ramp-up is compressing near-term margins and profitability, but the underlying mature hospital business remains strong with improving ARPOB and high occupancy. The Jamshedpur expansion and asset-light model provide a clear multi-year growth path.